← Back to Search

Procedure

Advanced Cochlear Implant Programming for Hearing Loss (TFS4CIs Trial)

N/A
Recruiting
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Younger than 18 years.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measure collected at 4-week midpoint during psychophysical training.
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether adding back information that cochlear implants discard can improve music and speech perception for users.

Who is the study for?
This trial is for cochlear implant users who want to improve their music and speech perception. It's not open to anyone under the age of 18.
What is being tested?
The study tests how changing stimulation rates and electrode locations in cochlear implants affects the user's ability to perceive music and speech by including temporal fine structure information.
What are the potential side effects?
Since this trial involves non-pharmaceutical interventions, typical drug side effects are not expected. However, changes in implant settings may cause discomfort or require an adjustment period.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measure collected at 8-week endpoint following psychophysical training.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measure collected at 8-week endpoint following psychophysical training. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Baseline electrode psychophysics prior to training.
Endpoint electrode psychophysics.
Midpoint electrode psychophysics.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stimulation RateExperimental Treatment2 Interventions
Group II: Electrode LocationActive Control2 Interventions

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
944 Previous Clinical Trials
1,604,621 Total Patients Enrolled
8 Trials studying Hearing Loss
1,282 Patients Enrolled for Hearing Loss
University of RochesterOTHER
868 Previous Clinical Trials
549,098 Total Patients Enrolled
2 Trials studying Hearing Loss
326 Patients Enrolled for Hearing Loss
Ohio State UniversityOTHER
866 Previous Clinical Trials
655,100 Total Patients Enrolled
6 Trials studying Hearing Loss
322 Patients Enrolled for Hearing Loss

Media Library

Electrode Location (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04708717 — N/A
Hearing Loss Research Study Groups: Stimulation Rate, Electrode Location
Hearing Loss Clinical Trial 2023: Electrode Location Highlights & Side Effects. Trial Name: NCT04708717 — N/A
Electrode Location (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04708717 — N/A
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top